161
Werewolf Therapeutics, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
Assets
(positive)
Change from FY21 to FY25
millions USD
FY21:
FY22:
140
FY23:
138
FY24:
113
FY25:
58.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
18.2
FY22:
20.0
FY23:
36.5
FY24:
13.9
FY25:
10.8
Total assets
Change from FY21 to FY25
millions USD
FY21:
179
FY22:
160
FY23:
175
FY24:
127
FY25:
69.4
Liabilities & Equity
(negative)
Change from FY21 to FY25
millions USD
FY21:
11.9
FY22:
24.0
FY23:
19.4
FY24:
15.2
FY25:
36.1
(negative)
Change from FY21 to FY25
millions USD
FY21:
14.6
FY22:
13.9
FY23:
44.1
FY24:
38.4
FY25:
8.44
(positive)
Change from FY21 to FY25
millions USD
FY21:
153
FY22:
122
FY23:
111
FY24:
73.4
FY25:
24.8
Total liabilities & equity
Change from FY21 to FY25
millions USD
FY21:
179
FY22:
160
FY23:
175
FY24:
127
FY25:
69.4
All amounts in millions USD